Laparoscopic Staging in Patients with Newly Diagnosed Pancreatic Cancer View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2018-04-12

AUTHORS

Timothy Gilbert , Ryan Baron , Paula Ghaneh , Christopher Halloran

ABSTRACT

Prompt accurate staging See Staging laparoscopy (SL)is paramount in managing patients with newly diagnosed pancreatic cancer. Initially, diagnosis and staging are undertaken using contrast-enhanced multidetector computerized tomography (CE-MDCT) or magnetic resonance imaging (MRI), supplemented with endoscopic ultrasound in selected cases. Staging laparoscopy (SL) with or without laparoscopic ultrasound (L-LUS) has been found to detect occult disease in 13–28% of patients with pancreatic cancer who are considered potentially resectable on imaging; however, between 1% and 30% of patients thought to be resectable on SL/L-LUS have subsequently been found to have unresectable disease. The clinical utility of SL/L-LUS can be enhanced by adopting a selective approach, only undertaking SL/L-LUS when one or more criteria are present, including (1) presumed pancreatic primary >3 cm diameter, (2) lesions in the body and tail of the pancreas, (3) CA 19–9>150 kU/L (>300 when total bilirubin >35 micromol/L), and (4) platelet/lymphocyte ratio >150. The judicious use of SL/L-LUS and cross-sectional imaging are complementary; however, the advent of PET-CT may lead to improvements in the detection of small previously radiologically occult metastases and may reduce the future role of SL/L-LUS. More... »

PAGES

753-769

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4939-7193-0_80

DOI

http://dx.doi.org/10.1007/978-1-4939-7193-0_80

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1103221537


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gilbert", 
        "givenName": "Timothy", 
        "id": "sg:person.014614756205.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014614756205.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baron", 
        "givenName": "Ryan", 
        "id": "sg:person.013334614633.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013334614633.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Surgery, The Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK", 
            "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ghaneh", 
        "givenName": "Paula", 
        "id": "sg:person.07372440237.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Halloran", 
        "givenName": "Christopher", 
        "id": "sg:person.0757621000.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757621000.67"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2018-04-12", 
    "datePublishedReg": "2018-04-12", 
    "description": "Prompt accurate staging See Staging laparoscopy (SL)is paramount in managing patients with newly diagnosed pancreatic cancer. Initially, diagnosis and staging are undertaken using contrast-enhanced multidetector computerized tomography (CE-MDCT) or magnetic resonance imaging (MRI), supplemented with endoscopic ultrasound in selected cases. Staging laparoscopy (SL) with or without laparoscopic ultrasound (L-LUS) has been found to detect occult disease in 13\u201328% of patients with pancreatic cancer who are considered potentially resectable on imaging; however, between 1% and 30% of patients thought to be resectable on SL/L-LUS have subsequently been found to have unresectable disease. The clinical utility of SL/L-LUS can be enhanced by adopting a selective approach, only undertaking SL/L-LUS when one or more criteria are present, including (1) presumed pancreatic primary >3\u00a0cm diameter, (2) lesions in the body and tail of the pancreas, (3) CA 19\u20139>150\u00a0kU/L (>300 when total bilirubin >35\u00a0micromol/L), and (4) platelet/lymphocyte ratio >150. The judicious use of SL/L-LUS and cross-sectional imaging are complementary; however, the advent of PET-CT may lead to improvements in the detection of small previously radiologically occult metastases and may reduce the future role of SL/L-LUS.", 
    "editor": [
      {
        "familyName": "Neoptolemos", 
        "givenName": "John P.", 
        "type": "Person"
      }, 
      {
        "familyName": "Urrutia", 
        "givenName": "Raul", 
        "type": "Person"
      }, 
      {
        "familyName": "Abbruzzese", 
        "givenName": "James L.", 
        "type": "Person"
      }, 
      {
        "familyName": "B\u00fcchler", 
        "givenName": "Markus W.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4939-7193-0_80", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4939-7191-6", 
        "978-1-4939-7193-0"
      ], 
      "name": "Pancreatic Cancer", 
      "type": "Book"
    }, 
    "keywords": [
      "pancreatic cancer", 
      "magnetic resonance imaging", 
      "platelet/lymphocyte ratio", 
      "multidetector computerized tomography", 
      "kU/L", 
      "cross-sectional imaging", 
      "unresectable disease", 
      "occult metastases", 
      "laparoscopic staging", 
      "occult disease", 
      "lymphocyte ratio", 
      "accurate staging", 
      "pancreatic primary", 
      "CA 19", 
      "endoscopic ultrasound", 
      "PET-CT", 
      "laparoscopic ultrasound", 
      "clinical utility", 
      "computerized tomography", 
      "patients", 
      "resonance imaging", 
      "staging", 
      "cancer", 
      "judicious use", 
      "disease", 
      "selective approach", 
      "ultrasound", 
      "more criteria", 
      "imaging", 
      "laparoscopy", 
      "metastasis", 
      "future role", 
      "lesions", 
      "pancreas", 
      "diagnosis", 
      "tomography", 
      "Newly", 
      "primary", 
      "criteria", 
      "cases", 
      "role", 
      "utility", 
      "improvement", 
      "body", 
      "use", 
      "advent", 
      "detection", 
      "paramount", 
      "ratio", 
      "diameter", 
      "tail", 
      "approach"
    ], 
    "name": "Laparoscopic Staging in Patients with Newly Diagnosed Pancreatic Cancer", 
    "pagination": "753-769", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1103221537"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4939-7193-0_80"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4939-7193-0_80", 
      "https://app.dimensions.ai/details/publication/pub.1103221537"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-09-02T16:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/chapter/chapter_51.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4939-7193-0_80"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-7193-0_80'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-7193-0_80'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-7193-0_80'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-7193-0_80'


 

This table displays all metadata directly associated to this object as RDF triples.

148 TRIPLES      22 PREDICATES      76 URIs      69 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4939-7193-0_80 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N75f79182a9a6416b82b45456139515fc
4 schema:datePublished 2018-04-12
5 schema:datePublishedReg 2018-04-12
6 schema:description Prompt accurate staging See Staging laparoscopy (SL)is paramount in managing patients with newly diagnosed pancreatic cancer. Initially, diagnosis and staging are undertaken using contrast-enhanced multidetector computerized tomography (CE-MDCT) or magnetic resonance imaging (MRI), supplemented with endoscopic ultrasound in selected cases. Staging laparoscopy (SL) with or without laparoscopic ultrasound (L-LUS) has been found to detect occult disease in 13–28% of patients with pancreatic cancer who are considered potentially resectable on imaging; however, between 1% and 30% of patients thought to be resectable on SL/L-LUS have subsequently been found to have unresectable disease. The clinical utility of SL/L-LUS can be enhanced by adopting a selective approach, only undertaking SL/L-LUS when one or more criteria are present, including (1) presumed pancreatic primary >3 cm diameter, (2) lesions in the body and tail of the pancreas, (3) CA 19–9>150 kU/L (>300 when total bilirubin >35 micromol/L), and (4) platelet/lymphocyte ratio >150. The judicious use of SL/L-LUS and cross-sectional imaging are complementary; however, the advent of PET-CT may lead to improvements in the detection of small previously radiologically occult metastases and may reduce the future role of SL/L-LUS.
7 schema:editor N53bad662b3d7408fbd4760fdd35485c2
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N670bde1d3e22408f8febab093a66108b
11 schema:keywords CA 19
12 Newly
13 PET-CT
14 accurate staging
15 advent
16 approach
17 body
18 cancer
19 cases
20 clinical utility
21 computerized tomography
22 criteria
23 cross-sectional imaging
24 detection
25 diagnosis
26 diameter
27 disease
28 endoscopic ultrasound
29 future role
30 imaging
31 improvement
32 judicious use
33 kU/L
34 laparoscopic staging
35 laparoscopic ultrasound
36 laparoscopy
37 lesions
38 lymphocyte ratio
39 magnetic resonance imaging
40 metastasis
41 more criteria
42 multidetector computerized tomography
43 occult disease
44 occult metastases
45 pancreas
46 pancreatic cancer
47 pancreatic primary
48 paramount
49 patients
50 platelet/lymphocyte ratio
51 primary
52 ratio
53 resonance imaging
54 role
55 selective approach
56 staging
57 tail
58 tomography
59 ultrasound
60 unresectable disease
61 use
62 utility
63 schema:name Laparoscopic Staging in Patients with Newly Diagnosed Pancreatic Cancer
64 schema:pagination 753-769
65 schema:productId N3c7e255133d44f9d9d3be6644b090f4c
66 Ncc27b4ed70b34912b039cb3b288776f6
67 schema:publisher N3ba40112e76e4e998342e6c8798e4e36
68 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103221537
69 https://doi.org/10.1007/978-1-4939-7193-0_80
70 schema:sdDatePublished 2022-09-02T16:18
71 schema:sdLicense https://scigraph.springernature.com/explorer/license/
72 schema:sdPublisher N422a3f2157634bae9c46b55434f70514
73 schema:url https://doi.org/10.1007/978-1-4939-7193-0_80
74 sgo:license sg:explorer/license/
75 sgo:sdDataset chapters
76 rdf:type schema:Chapter
77 N0ca00c42059846b6a81072dc3de06e4a schema:familyName Büchler
78 schema:givenName Markus W.
79 rdf:type schema:Person
80 N1446e6c718c1494a96347b95e13211b0 schema:familyName Urrutia
81 schema:givenName Raul
82 rdf:type schema:Person
83 N3ba40112e76e4e998342e6c8798e4e36 schema:name Springer Nature
84 rdf:type schema:Organisation
85 N3c7e255133d44f9d9d3be6644b090f4c schema:name dimensions_id
86 schema:value pub.1103221537
87 rdf:type schema:PropertyValue
88 N3d79dba403724fbb9ffa3c83fe7d87cb rdf:first sg:person.07372440237.86
89 rdf:rest Nd73bcf29d8f142b7a2d054915005e694
90 N422a3f2157634bae9c46b55434f70514 schema:name Springer Nature - SN SciGraph project
91 rdf:type schema:Organization
92 N53bad662b3d7408fbd4760fdd35485c2 rdf:first N85e78208f93548a6a92f8db1f84cfab8
93 rdf:rest Nbd8079c19c564d3db97885dfbaf2dc35
94 N670bde1d3e22408f8febab093a66108b schema:isbn 978-1-4939-7191-6
95 978-1-4939-7193-0
96 schema:name Pancreatic Cancer
97 rdf:type schema:Book
98 N6d3ef25315f546b49af7a0198ab68a45 schema:familyName Abbruzzese
99 schema:givenName James L.
100 rdf:type schema:Person
101 N75f79182a9a6416b82b45456139515fc rdf:first sg:person.014614756205.88
102 rdf:rest N79452f53faeb49c697e4b671d33e4f41
103 N79452f53faeb49c697e4b671d33e4f41 rdf:first sg:person.013334614633.40
104 rdf:rest N3d79dba403724fbb9ffa3c83fe7d87cb
105 N8405b4bf0ee54df79799d2595c7c5628 rdf:first N6d3ef25315f546b49af7a0198ab68a45
106 rdf:rest Nd7eca7c5dfa34d338933cf0db7e1d8b3
107 N85e78208f93548a6a92f8db1f84cfab8 schema:familyName Neoptolemos
108 schema:givenName John P.
109 rdf:type schema:Person
110 Nbd8079c19c564d3db97885dfbaf2dc35 rdf:first N1446e6c718c1494a96347b95e13211b0
111 rdf:rest N8405b4bf0ee54df79799d2595c7c5628
112 Ncc27b4ed70b34912b039cb3b288776f6 schema:name doi
113 schema:value 10.1007/978-1-4939-7193-0_80
114 rdf:type schema:PropertyValue
115 Nd73bcf29d8f142b7a2d054915005e694 rdf:first sg:person.0757621000.67
116 rdf:rest rdf:nil
117 Nd7eca7c5dfa34d338933cf0db7e1d8b3 rdf:first N0ca00c42059846b6a81072dc3de06e4a
118 rdf:rest rdf:nil
119 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
120 schema:name Medical and Health Sciences
121 rdf:type schema:DefinedTerm
122 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
123 schema:name Oncology and Carcinogenesis
124 rdf:type schema:DefinedTerm
125 sg:person.013334614633.40 schema:affiliation grid-institutes:grid.10025.36
126 schema:familyName Baron
127 schema:givenName Ryan
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013334614633.40
129 rdf:type schema:Person
130 sg:person.014614756205.88 schema:affiliation grid-institutes:grid.10025.36
131 schema:familyName Gilbert
132 schema:givenName Timothy
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014614756205.88
134 rdf:type schema:Person
135 sg:person.07372440237.86 schema:affiliation grid-institutes:grid.10025.36
136 schema:familyName Ghaneh
137 schema:givenName Paula
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86
139 rdf:type schema:Person
140 sg:person.0757621000.67 schema:affiliation grid-institutes:grid.10025.36
141 schema:familyName Halloran
142 schema:givenName Christopher
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757621000.67
144 rdf:type schema:Person
145 grid-institutes:grid.10025.36 schema:alternateName Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK
146 schema:name Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK
147 Department of Surgery, The Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK
148 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...